FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to compounds of the general formula (I): 
wherein R1 and R2 can be similar or different and mean branched or direct (C1-C6)-alkyl chain; R3 and R4 form in common a ring chosen from the group including pyrrolyl, imidazolyl, pyrazolyl, indolyl, indolinyl, pyrrolidinyl, piperazinyl and piperidyl and comprising nitrogen atom to which they are bound, and to their pharmaceutically acceptable salts also. Also, invention relates to a pharmaceutical composition possessing anti-hyperglycemic activity. Pharmaceutical composition comprises compound of the formula (I) as an active substance and an inert excipient. Invention provides using derivatives of biguanide possessing anti-hyperglycemic activity.
EFFECT: valuable medicinal property of derivatives.
9 cl, 2 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PANCREATIC DIABETES DRUG | 2004 |
|
RU2358738C2 |
| O-ARYLGLUCOSIDE INHIBITORS OF SGLT2 AND METHOD FOR THEIR USING | 2001 |
|
RU2269540C2 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIDIABETIC, HYPOLIPIDEMIC, HYPOGLYCEMIC AND CHOLESTEROL LOWERING ACTION, WAY OF ITS RECEPTION AND WAYS OF TREATMENT OF SPECIFIED DISEASES | 2007 |
|
RU2361581C2 |
| METHODS FOR PROPHYLAXIS AND TREATMENT, APPLICATION OF AGENT TO ENHANCE INSULIN SUSCEPTIBILITY | 2003 |
|
RU2286148C2 |
| COMPOSITIONS AND METHODS FOR TREATING DIABETES | 2004 |
|
RU2367423C2 |
| PHARMACEUTICAL COMBINATION CONTAINING SGLT2 INHIBITOR | 2008 |
|
RU2489151C2 |
| NOVEL VANADIUM DERIVATIVES HAVING HYPOGLYCEMIC ACTIVITY | 2019 |
|
RU2709491C1 |
| METHOD FOR TREATING METABOLISM DISORDERS MAINLY DIABETES CASES AND DISEASES OR STATES RELATED TO DIABETES | 2000 |
|
RU2280447C2 |
| METHOD OF PREVENTION AND TREATMENT AND RELATED COMPLICATION | 1996 |
|
RU2327455C2 |
| PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2198682C2 |
